What is the difference between Atorvastatin and FENOFIBRATE?

Atorvastatin is a HMG-CoA Reductase Inhibitor (Statin) and FENOFIBRATE is a Fibrate. They reach a similar treatment goal through different pharmacological mechanisms, which is why one may be tolerated by a patient who could not tolerate the other.

Can Atorvastatin and FENOFIBRATE be used for the same conditions?

Both medications are prescribed for overlapping indications including Hyperlipidemia and Primary prevention of cardiovascular disease. Always verify with your prescriber and the current FDA label before switching.

Is Lipitor the same as Fenofibrate?

No. Lipitor (Atorvastatin) and Fenofibrate (FENOFIBRATE) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, Atorvastatin or FENOFIBRATE?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from Atorvastatin to FENOFIBRATE?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

Atorvastatin vs FENOFIBRATE

Compare Atorvastatin (Lipitor) and FENOFIBRATE (Fenofibrate) — clinical data, side effects, and patient experiences.

Atorvastatin

Lipitor · HMG-CoA Reductase Inhibitor (Statin)

How it works

Competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to upregulation of LDL receptors and increased clearance of LDL-cholesterol ...

Approved for

Hyperlipidemia

Primary prevention of cardiovascular disease

Secondary prevention post-ACS

t½: 14 hoursFDA: 1996OralTablet

FENOFIBRATE

Fenofibrate, Tricor, Fenoglide · Fibrate

How it works

12.1 Mechanism of Action The active moiety of fenofibrate is fenofibric acid. The pharmacological effects of fenofibric acid in both animals and humans have been extensively studie...

Approved for

1 INDICATIONS AND USAGE Fenofibrate tablet USP is a peroxisome proliferator-activated receptor (PPAR) alpha agonist indicated as an adjunct to diet: To reduce elevated LDL-C

Total-C

TG and Apo B

total cholesterol (Total-C)

OralTablet

Quick Comparison

AtorvastatinFENOFIBRATE

Drug Class

HMG-CoA Reductase Inhibitor (Statin)

Fibrate

Route

Oral

Half-Life

14 hours

—

FDA Approved

1996

—

Pregnancy

—

Efficacy Rating

9.0/10

0.0/10

Tolerability

7.0/10

0.0/10

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Atorvastatin

Muscle Pain

1-10%

Joint Pain

1-10%

Diarrhea

1-10%

FENOFIBRATE

Nausea

1-10%

Fatigue

1-10%

Diarrhea

1-10%

Drug Not Working

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Dizziness

1-10%

Weakness

1-10%

FDA Warnings

Atorvastatin

Rhabdomyolysis risk (rare)
Hepatotoxicity — monitor LFTs
May increase HbA1c and fasting glucose

FENOFIBRATE

5 WARNINGS AND PRECAUTIONS Hepatotoxicity : Serious drug-induced liver injury, including liver transplantation and death, has been reported with fenofibrate
Risks are increased during co-administration with a statin (with a significantly higher rate observed for gemfibrozil), particularly in elderly patients and patients with diabetes, renal failure, or hypothyroidism ( 5
Cholelithiasis: Fenofibrate increases cholesterol excretion into the bile, leading to risk of cholelithiasis
The Action to Control Cardiovascular Risk in Diabetes Lipid (ACCORD Lipid) trial was a randomized placebo-controlled study of 5518 patients with type 2 diabetes mellitus on background statin therapy treated with fenofibrate

Community Sentiment Analysis

Based on 19 Reddit discussions

Atorvastatin

positive

14 threads

FENOFIBRATE

positive

5 threads

Community-Reported Side Effects

% of discussions mentioning each side effect

Head-to-Head Ratings

Patient Real-World Experience

Based on 1 verified patient review

Atorvastatin (1)

FENOFIBRATE (0)

Efficacy

9.0/100.0/10

Tolerability

7.0/100.0/10

Overall Satisfaction

8.0/100.0/10

Atorvastatin Side Effects

No data yet

FENOFIBRATE Side Effects

No data yet

Avg. Duration

36 months

100% still taking

Avg. Duration

0 months

0% still taking

Atorvastatin vs FENOFIBRATE: What You Should Know

Key Differences

Atorvastatin is a HMG-CoA Reductase Inhibitor (Statin), while FENOFIBRATE belongs to the Fibrate class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles.

Patient Experience

Atorvastatin has an average efficacy rating of 9.0/10 and tolerability of 7.0/10 across 1 patient review. Patient-reported outcomes provide real-world context beyond clinical trials, though individual responses to medication vary significantly..

Safety Considerations

Atorvastatin carries 3 FDA warnings. FENOFIBRATE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

Atorvastatin vs Rosuvastatin→FENOFIBRATE vs GEMFIBROZIL→Atorvastatin vs SIMVASTATIN→Atorvastatin vs PITAVASTATIN→ALIROCUMAB vs Atorvastatin→Atorvastatin vs EZETIMIBE→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

Atorvastatin: DailyMed label · FAERS adverse events · ClinicalTrials.gov
FENOFIBRATE: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

Atorvastatin vs FENOFIBRATE

Compare Atorvastatin (Lipitor) and FENOFIBRATE (Fenofibrate) — clinical data, side effects, and patient experiences.

Atorvastatin

Lipitor · HMG-CoA Reductase Inhibitor (Statin)

How it works

Competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to upregulation of LDL receptors and increased clearance of LDL-cholesterol ...

Approved for

Hyperlipidemia

Primary prevention of cardiovascular disease

Secondary prevention post-ACS

t½: 14 hoursFDA: 1996OralTablet

FENOFIBRATE

Fenofibrate, Tricor, Fenoglide · Fibrate

How it works

12.1 Mechanism of Action The active moiety of fenofibrate is fenofibric acid. The pharmacological effects of fenofibric acid in both animals and humans have been extensively studie...

Approved for

1 INDICATIONS AND USAGE Fenofibrate tablet USP is a peroxisome proliferator-activated receptor (PPAR) alpha agonist indicated as an adjunct to diet: To reduce elevated LDL-C

Total-C

TG and Apo B

total cholesterol (Total-C)

OralTablet

Quick Comparison

AtorvastatinFENOFIBRATE

Drug Class

HMG-CoA Reductase Inhibitor (Statin)

Fibrate

Route

Oral

Half-Life

14 hours

—

FDA Approved

1996

—

Pregnancy

—

Efficacy Rating

9.0/10

0.0/10

Tolerability

7.0/10

0.0/10

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Atorvastatin

Muscle Pain

1-10%

Joint Pain

1-10%

Diarrhea

1-10%

FENOFIBRATE

Nausea

1-10%

Fatigue

1-10%

Diarrhea

1-10%

Drug Not Working

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Dizziness

1-10%

Weakness

1-10%

FDA Warnings

Atorvastatin

Rhabdomyolysis risk (rare)
Hepatotoxicity — monitor LFTs
May increase HbA1c and fasting glucose

FENOFIBRATE

5 WARNINGS AND PRECAUTIONS Hepatotoxicity : Serious drug-induced liver injury, including liver transplantation and death, has been reported with fenofibrate
Risks are increased during co-administration with a statin (with a significantly higher rate observed for gemfibrozil), particularly in elderly patients and patients with diabetes, renal failure, or hypothyroidism ( 5
Cholelithiasis: Fenofibrate increases cholesterol excretion into the bile, leading to risk of cholelithiasis
The Action to Control Cardiovascular Risk in Diabetes Lipid (ACCORD Lipid) trial was a randomized placebo-controlled study of 5518 patients with type 2 diabetes mellitus on background statin therapy treated with fenofibrate

Community Sentiment Analysis

Based on 19 Reddit discussions

Atorvastatin

positive

14 threads

FENOFIBRATE

positive

5 threads

Community-Reported Side Effects

% of discussions mentioning each side effect

Head-to-Head Ratings

Patient Real-World Experience

Based on 1 verified patient review

Atorvastatin (1)

FENOFIBRATE (0)

Efficacy

9.0/100.0/10

Tolerability

7.0/100.0/10

Overall Satisfaction

8.0/100.0/10

Atorvastatin Side Effects

No data yet

FENOFIBRATE Side Effects

No data yet

Avg. Duration

36 months

100% still taking

Avg. Duration

0 months

0% still taking

Atorvastatin vs FENOFIBRATE: What You Should Know

Key Differences

Patient Experience

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.